1至36月龄儿童癫痫的手术治疗:一项系统评价
美国癫痫学会委托的系统评价,检索1999年1月1日至2021年8月19日文献,纳入18项研究(19篇文章),评估1至36月龄(不含婴儿痉挛症)癫痫患儿手术或神经刺激的疗效与危害。半球切除术/半球切开术后1年无发作率7%至76%,非半球手术无发作率40%至70%,证据强度低。
要点
- 半球切除术/半球切开术后1年无发作率7%至76%,非半球手术无发作率40%至70%。
- 超过半数半球切除术/半球切开术患儿随访>1年达到良好结局(Engel I或II、ILAE I至IV或发作减少>50%)。
- 功能半球切除术/半球切开术和非半球切除术的手术死亡率罕见,非半球手术术后脑积水不常见(低证据强度)。
核心结论
- 现有证据稀疏且质量低,但部分患儿术后可达无发作,≥50%达到良好结局;需未来前瞻性研究,并评估发育结局、生活质量、睡眠、功能表现和照护者生活质量。
研究设计与样本
- 美国癫痫学会委托的系统评价,检索EMBASE、MEDLINE、PubMed和Cochrane Library从1999年1月1日至2021年8月19日发表的文献。
- 纳入报告1月龄至≤36月龄癫痫患儿接受手术或神经刺激、每种操作≥10例的研究,排除婴儿痉挛症或癫痫持续状态研究。
- 疗效结局要求随访≥12周,危害结局无最低随访要求;共18项研究(19篇文章)符合纳入标准,16项前后对照研究报告疗效,12项研究报告危害。
主要发现
- 手术实施时间为1979年至2020年。
- 接受半球切除术/半球切开术的婴儿术后1年无发作率范围为7%至76%。
- 非半球手术的无发作率范围为40%至70%。
- 超过半数接受半球切除术/半球切开术的婴儿在>1年随访时达到良好结局(Engel I或II、国际抗癫痫联盟I至IV或发作减少>50%),但研究存在关键局限性。
- 功能半球切除术/半球切开术和非半球切除术的手术死亡率罕见;低证据强度提示非半球手术术后脑积水不常见。
关键数值与推荐
- 半球切除术/半球切开术后1年无发作率7%至76%。
- 非半球手术无发作率40%至70%。
- 超过半数半球切除术/半球切开术患儿随访>1年达到良好结局(Engel I或II、ILAE I至IV或发作减少>50%)。
- 低证据强度(SOE)提示部分婴儿术后可达无发作。
- 低证据强度提示非半球手术术后脑积水不常见。
临床怎么用
- 原文未据此给出推荐。
局限性
- 现有证据稀疏且质量低。
- 研究存在关键局限性。
- 需未来针对该年龄组的前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Early life epilepsies (epilepsies in children 1-36 months old) are common and may be refractory to antiseizure medications. We summarize findings of a systematic review commissioned by the American Epilepsy Society to assess evidence and identify evidence gaps for surgical treatments for epilepsy in children aged 1-36 months without infantile spasms. METHODS: EMBASE, MEDLINE, PubMed, and the Cochrane Library were searched for studies published from 1/1/1999 to 8/19/21. We included studies reporting data on children aged 1 month to ≤36 months undergoing surgical interventions or neurostimulation for epilepsy and enrolling ≥10 patients per procedure. We excluded studies of infants with infantile spasms or status epilepticus. For effectiveness outcomes (seizure freedom, seizure frequency), studies were required to report follow-up at ≥ 12 weeks. For harm outcomes, no minimum follow-up was required. Outcomes for all epilepsy types, regardless of etiology, were reported together. RESULTS: Eighteen studies (in 19 articles) met the inclusion criteria. Sixteen prestudies/poststudies reported on efficacy, and 12 studies addressed harms. Surgeries were performed from 1979 to 2020. Seizure freedom for infants undergoing hemispherectomy/hemispherotomy ranged from 7% to 76% at 1 year after surgery. For nonhemispheric surgeries, seizure freedom ranged from 40% to 70%. For efficacy, we concluded low strength of evidence (SOE) suggests some infants achieve seizure freedom after epilepsy surgery. Over half of infants undergoing hemispherectomy/hemispherotomy achieved a favorable outcome (Engel I or II, International League Against Epilepsy I to IV, or >50% seizure reduction) at follow-up of >1 year, although studies had key limitations. Surgical mortality was rare for functional hemispherectomy/hemispherotomy and nonhemispheric resections. Low SOE suggests postoperative hydrocephalus is uncommon for infants undergoing nonhemispheric procedures for epilepsy. DISCUSSION: Although existing evidence remains sparse and low quality, some infants achieve seizure freedom after surgery and ≥50% achieve favorable outcomes. Future prospective studies in this age group are needed. In addition to seizure outcomes, studies should evaluate other important outcomes (developmental outcomes, quality of life [QOL], sleep, functional performance, and caregiver QOL). TRIAL REGISTRATION INFORMATION: This systematic review was registered in PROSPERO (CRD42021220352) on March 5, 2021.
引用
- Tsou AY, Kessler SK, Wu M, et al. Surgical Treatments for Epilepsies in Children Aged 1-36 Months: A Systematic Review. Neurology. 2022. PMID: 36270898. doi:10.1212/WNL.0000000000201012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。